4-[3-[(2,6-difluorophenyl)sulfonylmethyl]phenyl]-2-(oxan-4-yl)-5-pyridin-4-yl-1,3-thiazole
C26H22F2N2O3S2 — CID 148845927
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[3-[(2,6-difluorophenyl)sulfonylmethyl]phenyl]-2-(oxan-4-yl)-5-pyridin-4-yl-1,3-thiazole
4-[3-[(2,6-difluorophenyl)sulfonylmethyl]phenyl]-2-(oxan-4-yl)-5-pyridin-4-yl-1,3-thiazole (PubChem CID 148845927) has the molecular formula C26H22F2N2O3S2 and a molecular weight of 512.60 g/mol. Its IUPAC name is 4-[3-[(2,6-difluorophenyl)sulfonylmethyl]phenyl]-2-(oxan-4-yl)-5-pyridin-4-yl-1,3-thiazole.
Molecular Properties
| Compound Name | 4-[3-[(2,6-difluorophenyl)sulfonylmethyl]phenyl]-2-(oxan-4-yl)-5-pyridin-4-yl-1,3-thiazole |
|---|---|
| PubChem CID | 148845927 |
| Molecular Formula | C26H22F2N2O3S2 |
| Molecular Weight | 512.60 g/mol |
| Exact Mass | 512.10 |
| IUPAC Name | 4-[3-[(2,6-difluorophenyl)sulfonylmethyl]phenyl]-2-(oxan-4-yl)-5-pyridin-4-yl-1,3-thiazole |
| SMILES | O=S(=O)(Cc1cccc(-c2nc(C3CCOCC3)sc2-c2ccncc2)c1)c1c(F)cccc1F |
| InChI | InChI=1S/C26H22F2N2O3S2/c27-21-5-2-6-22(28)25(21)35(31,32)16-17-3-1-4-20(15-17)23-24(18-7-11-29-12-8-18)34-26(30-23)19-9-13-33-14-10-19/h1-8,11-12,15,19H,9-10,13-14,16H2 |
| InChIKey | OWLSDGHHGDMQJX-UHFFFAOYSA-N |
| XLogP | 6.02 |
| TPSA | 69.15 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 512.60 |
| LogP ≤ 5 | 6.02 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 148845927 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.